Gel Coat Biomaterials, Inc.

Gel Coat Biomaterials, Inc.

Private
TokyoEnergy & Sustainabilityhttps://www.gelcoatbio.com/

Last Round

Series A

Apr 27, 2026

Total Funding Raised

$2.62M

Momentum Score

25 /100

Company Overview

Gel Coat Biomaterials, Inc. is a Japanese biotechnology company founded in 2024 that is developing a novel hydrogel technology for the stabilization of enzymes and other biomolecules. The company's core technology, "Amoeba Hydrogel," was originally developed at The University of Tokyo and is designed to encapsulate biomaterials, protecting them and allowing them to function under harsh conditions. This enables applications in various fields, including environmental, chemical, and medical. The company aims to address social issues like global warming and resource recycling, as well as to develop new medical technologies for diseases that have been difficult to treat. Gel Coat Biomaterials raised a $1.34M seed round in February 2024, with Waseda University Ventures as an investor.

Sector

Energy & Sustainability

Verticals

Sustainable Materials, Advanced Materials, Biotechnology, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

algae-based polyolspolyolsbiomaterialspolyurethanesdrop-in replacementfossil fuel replacementcarbon negative materialsbio-based chemicalsalgae techautomotive materialssupply chain decarbonizationgreen chemicalssustainable foamsapparel materialsfootwear materialshydrogels

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gel Coat Biomaterials, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Gel Coat Biomaterials, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AApr 27, 2026
SeedFeb 22, 2024

Gel Coat Biomaterials, Inc. Investors

Notable investors and investment history

InvestorRounds
WASEDA University VenturesSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    $1.26M round led by WASEDA University Ventures

  • Apr 20, 2026

    Monthly visitors increased 31% MoM.

Gel Coat Biomaterials, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Gel Coat Biomaterials, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gel Coat Biomaterials, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range2
Year Founded2024
Last FundingApr 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.